93% of Prostate MRI Patients Did Not Need Contrast. Here Is the Proof.

If your department is still running full multiparametric MRI (mp-MRI) protocols for every prostate exam, this study should make you reconsider.

Researchers have demonstrated that replacing mp-MRI with biparametric MRI (bp-MRI) and a selective contrast recall system maintained identical PI-RADS categorization while sparing 93.4% of patients from intravenous contrast entirely.

What Changed and What Did Not

The team compared 225 consecutive mp-MRI exams performed before protocol implementation with 225 consecutive bp-MRI exams performed after. The result: no statistically significant difference in PI-RADS distribution between the two groups.

In other words, the diagnostic risk stratification that urologists rely on to make biopsy decisions remained identical. Same clinical output, dramatically simplified protocol.

The selective recall system worked like this: if a bp-MRI exam showed an equivocal lesion, the patient was recalled for a targeted contrast-enhanced sequence. But this was needed in only 6.6% of cases (36 out of 547 patients). The vast majority walked out without ever needing an IV line.

Why This Matters Practically

Dropping contrast from routine prostate MRI does more than reduce gadolinium exposure. It shortens exam time, simplifies scheduling (no IV setup, no post-contrast monitoring), and frees up scanner slots. For departments running at capacity, which is most departments, this translates directly into more patients scanned per day.

The study team noted that it was this combination of protocol change plus operational efficiency gains that expanded patient access, not the protocol swap alone.

Implications for Indian Radiology

In India, where MRI scanner time is at a premium and contrast agents add meaningful cost per exam, bp-MRI adoption could have an outsized impact. Many institutions are already facing backlogs for prostate MRI. A protocol that cuts exam time by 30-40% while producing equivalent PI-RADS results is not an incremental improvement. It is a capacity multiplier.

Additionally, concerns about gadolinium deposition, while still debated globally, are increasingly part of the conversation with patients. Offering a contrast-free first-line exam is a patient-centered move that also happens to be operationally smart.

The Takeaway for Radiologists

The authors are not being subtle about their recommendation. They are encouraging other institutions to make the same switch, calling bp-MRI with a recall system a practical, patient-centered alternative to routine mp-MRI.

The evidence base for bp-MRI prostate has been building for years. This study adds implementation data showing it works in real clinical practice, not just in controlled research settings. If your department has not evaluated this protocol change yet, the question is no longer whether to consider it, but why you have not already.